JP2003531606A5 - - Google Patents

Download PDF

Info

Publication number
JP2003531606A5
JP2003531606A5 JP2001580320A JP2001580320A JP2003531606A5 JP 2003531606 A5 JP2003531606 A5 JP 2003531606A5 JP 2001580320 A JP2001580320 A JP 2001580320A JP 2001580320 A JP2001580320 A JP 2001580320A JP 2003531606 A5 JP2003531606 A5 JP 2003531606A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001580320A
Other versions
JP2003531606A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2001/000620 external-priority patent/WO2001083711A2/en
Publication of JP2003531606A publication Critical patent/JP2003531606A/ja
Publication of JP2003531606A5 publication Critical patent/JP2003531606A5/ja
Pending legal-status Critical Current

Links

JP2001580320A 2000-05-03 2001-05-02 混在した細胞性組成物からのｒａｓ介在性新生物細胞のレオウイルスクリアランス Pending JP2003531606A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US20199000P 2000-05-03 2000-05-03
US60/201,990 2000-05-03
US20538900P 2000-05-19 2000-05-19
US60/205,389 2000-05-19
US26805401P 2001-02-13 2001-02-13
US60/268,054 2001-02-13
PCT/CA2001/000620 WO2001083711A2 (en) 2000-05-03 2001-05-02 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008190310A Division JP2008278897A (ja) 2000-05-03 2008-07-23 混在した細胞性組成物からのｒａｓ介在性新生物細胞のレオウイルスクリアランス

Publications (2)

Publication Number Publication Date
JP2003531606A JP2003531606A (ja) 2003-10-28
JP2003531606A5 true JP2003531606A5 (ja) 2005-12-22

Family

ID=27394375

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001580320A Pending JP2003531606A (ja) 2000-05-03 2001-05-02 混在した細胞性組成物からのｒａｓ介在性新生物細胞のレオウイルスクリアランス
JP2008190310A Pending JP2008278897A (ja) 2000-05-03 2008-07-23 混在した細胞性組成物からのｒａｓ介在性新生物細胞のレオウイルスクリアランス
JP2010181396A Pending JP2010260875A (ja) 2000-05-03 2010-08-13 混在した細胞性組成物からのｒａｓ介在性新生物細胞のレオウイルスクリアランス

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2008190310A Pending JP2008278897A (ja) 2000-05-03 2008-07-23 混在した細胞性組成物からのｒａｓ介在性新生物細胞のレオウイルスクリアランス
JP2010181396A Pending JP2010260875A (ja) 2000-05-03 2010-08-13 混在した細胞性組成物からのｒａｓ介在性新生物細胞のレオウイルスクリアランス

Country Status (15)

Country Link
US (5) US6994858B2 (ja)
EP (2) EP1278824B1 (ja)
JP (3) JP2003531606A (ja)
AR (1) AR028039A1 (ja)
AT (1) ATE474040T1 (ja)
AU (2) AU5808601A (ja)
BR (1) BR0110474A (ja)
CA (1) CA2407894C (ja)
DE (1) DE60142559D1 (ja)
DK (1) DK1278824T3 (ja)
ES (1) ES2346182T3 (ja)
IL (2) IL152390A (ja)
MX (1) MXPA02010744A (ja)
NZ (1) NZ522179A (ja)
WO (1) WO2001083711A2 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6136307A (en) 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
US8491884B2 (en) 2000-05-03 2013-07-23 Oncolytics Biotech Inc. Virus clearance of neoplastic cells from mixed cellular compositions
US7306902B2 (en) * 2002-06-28 2007-12-11 Oncolyties Biotech Inc. Oncolytic viruses as phenotyping agents for neoplasms
AR028039A1 (es) * 2000-05-03 2003-04-23 Oncolytics Biotech Inc Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
AR028040A1 (es) * 2000-05-03 2003-04-23 Oncolytics Biotech Inc Remocion de virus de celulas neoplasticas a partir de composiciones celulares mixtas
JP5208343B2 (ja) 2000-06-26 2013-06-12 ウェルスタット バイオロジクス コーポレイション ウイルスを用いる細胞の浄化
TWI289158B (en) 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus
US20050214266A1 (en) * 2004-03-12 2005-09-29 Oncolytics Biotech Inc. Combination of transplantation and oncolytic virus treatment
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
CA2617600A1 (en) 2005-08-01 2007-09-07 University Technologies International, Inc. Attenuated reovirus
US10369171B2 (en) * 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
US20160306006A1 (en) * 2015-04-16 2016-10-20 HGST, Inc. Self-testing a storage device via system management bus interface

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1221307A (en) * 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent and process for preparing the same
US5637677A (en) * 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
AU2593192A (en) * 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
US5801029A (en) * 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
DE69426841T2 (de) 1993-02-16 2001-09-06 Onyx Pharma Inc Cytopatische Viren zur Therapie und Prophylaxe der Neoplasie
WO1994025627A1 (en) 1993-04-30 1994-11-10 Lorence Robert M Methods of treating and detecting cancer using viruses
CA2178902A1 (en) * 1993-12-14 1995-06-22 Drew Pardoll Controlled release of pharmaceutically active substances for immunotherapy
US5514340A (en) * 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
WO1995032300A1 (en) * 1994-05-23 1995-11-30 University Of Medicine & Dentistry Of New Jersey Selective biological destruction of tumor cells
US5585096A (en) * 1994-06-23 1996-12-17 Georgetown University Replication-competent herpes simplex virus mediates destruction of neoplastic cells
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US6136307A (en) 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US20030044384A1 (en) * 1997-10-09 2003-03-06 Pro-Virus, Inc. Treatment of neoplasms with viruses
US7780962B2 (en) 1997-10-09 2010-08-24 Wellstat Biologics Corporation Treatment of neoplasms with RNA viruses
DE69838340T2 (de) 1997-10-09 2008-05-21 Wellstat Biologics Corp. Behandlung von neoplasmen mit interferonempfindlichen, klonalen viren
US6475481B2 (en) * 1997-11-18 2002-11-05 Canji Inc Purging of stem cell products
WO1999045783A1 (en) 1998-03-12 1999-09-16 The Trustees Of The University Of Pennsylvania Producer cells for replication selective viruses in the treatment of malignancy
DE69929986T2 (de) * 1998-08-31 2006-10-19 Ambrus, Julian L. Verfahren zur entfernung von hiv und anderen viren aus blut
CA2388807C (en) 1999-11-12 2013-08-06 Matthew C. Coffey Viruses for the treatment of cellular proliferative disorders
AR028040A1 (es) * 2000-05-03 2003-04-23 Oncolytics Biotech Inc Remocion de virus de celulas neoplasticas a partir de composiciones celulares mixtas
AR028039A1 (es) * 2000-05-03 2003-04-23 Oncolytics Biotech Inc Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
JP5208343B2 (ja) * 2000-06-26 2013-06-12 ウェルスタット バイオロジクス コーポレイション ウイルスを用いる細胞の浄化

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ja)
BE2022C502I2 (ja)
BE2022C547I2 (ja)
BE2017C057I2 (ja)
BE2017C051I2 (ja)
BE2017C032I2 (ja)
BE2016C051I2 (ja)
BE2015C046I2 (ja)
BE2014C052I2 (ja)
BE2014C036I2 (ja)
BE2014C026I2 (ja)
BE2014C004I2 (ja)
BE2017C050I2 (ja)
BE2011C034I2 (ja)
BE2007C047I2 (ja)
AU2002307149A8 (ja)
BRPI0209186B1 (ja)
BE2014C008I2 (ja)
BRPI0204884B1 (ja)
CH1379220H1 (ja)
BE2016C021I2 (ja)
BE2017C059I2 (ja)
BRPI0101486B8 (ja)
BE2012C051I2 (ja)
JP2003531606A5 (ja)